These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8524449

  • 1. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM, Deveaux M, Duneton O, Foissac-Gegoux P, Dumont A, Duquesnoy B, Marchandise X.
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [Abstract] [Full Text] [Related]

  • 2. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB.
    Lancet; 1991 Aug 10; 338(8763):335-9. PubMed ID: 1677697
    [Abstract] [Full Text] [Related]

  • 3. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J, Schäffer J, Koch KM.
    Nephrol Dial Transplant; 2001 Aug 10; 16 Suppl 4():12-6. PubMed ID: 11402091
    [Abstract] [Full Text] [Related]

  • 4. 131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis.
    Gejyo F, Kazama JJ, Hasegawa S, Nishi S, Arakawa M, Odano I.
    Clin Nephrol; 1995 Nov 10; 44 Suppl 1():S14-8. PubMed ID: 8608655
    [Abstract] [Full Text] [Related]

  • 5. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
    Tan SY, Baillod R, Brown E, Farrington K, Soper C, Percy M, Clutterbuck E, Madhoo S, Pepys MB, Hawkins PN.
    Nephrol Dial Transplant; 1999 Jun 10; 14(6):1467-71. PubMed ID: 10383009
    [Abstract] [Full Text] [Related]

  • 6. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr 10; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 10; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 23; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.